These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 9383016

  • 1. Expression of c-Jun in dopaminergic neurons of the substantia nigra in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
    Nishi K.
    Brain Res; 1997 Oct 10; 771(1):133-41. PubMed ID: 9383016
    [Abstract] [Full Text] [Related]

  • 2. [Effect of phosphorylated c-Jun expression on COX-2 expression in the substantia nigra of MPTP mouse model of subacute Parkinson disease].
    Wang YS, Zhou JP, Wei ZF, Tian QY, Zhou HX, Zhang YX.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug 10; 27(8):1199-202, 1205. PubMed ID: 17715026
    [Abstract] [Full Text] [Related]

  • 3. Fluoro-Jade C can specifically stain the degenerative neurons in the substantia nigra of the 1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine-treated C57BL/6 mice.
    Bian GL, Wei LC, Shi M, Wang YQ, Cao R, Chen LW.
    Brain Res; 2007 May 30; 1150():55-61. PubMed ID: 17397812
    [Abstract] [Full Text] [Related]

  • 4. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    Hayley S, Crocker SJ, Smith PD, Shree T, Jackson-Lewis V, Przedborski S, Mount M, Slack R, Anisman H, Park DS.
    J Neurosci; 2004 Feb 25; 24(8):2045-53. PubMed ID: 14985447
    [Abstract] [Full Text] [Related]

  • 5. Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice.
    Sugama S, Yang L, Cho BP, DeGiorgio LA, Lorenzl S, Albers DS, Beal MF, Volpe BT, Joh TH.
    Brain Res; 2003 Feb 28; 964(2):288-94. PubMed ID: 12576189
    [Abstract] [Full Text] [Related]

  • 6. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
    Kim HW, Choi WS, Sorscher N, Park HJ, Tronche F, Palmiter RD, Xia Z.
    Neurobiol Aging; 2015 Sep 28; 36(9):2617-27. PubMed ID: 26070241
    [Abstract] [Full Text] [Related]

  • 7. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment.
    Knyihár-Csillik E, Csillik B, Pákáski M, Krisztin-Péva B, Dobó E, Okuno E, Vécsei L.
    Neuroscience; 2004 Sep 28; 126(4):899-914. PubMed ID: 15207325
    [Abstract] [Full Text] [Related]

  • 8. The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.
    Ding YX, Xia Y, Jiao XY, Duan L, Yu J, Wang X, Chen LW.
    Neurochem Res; 2011 Oct 28; 36(10):1759-66. PubMed ID: 21562748
    [Abstract] [Full Text] [Related]

  • 9. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E, Yano R, Yokoyama H, Kato H, Araki T.
    Exp Mol Pathol; 2009 Feb 28; 86(1):57-64. PubMed ID: 19027004
    [Abstract] [Full Text] [Related]

  • 10. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS, Brown EM, Miller MS, Carswell S.
    J Pharmacol Exp Ther; 1999 Feb 28; 288(2):421-7. PubMed ID: 9918541
    [Abstract] [Full Text] [Related]

  • 11. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW, Nixon K, Hogg E, McNeill T, Petzinger GM.
    J Neurosci Res; 2004 May 15; 76(4):539-50. PubMed ID: 15114626
    [Abstract] [Full Text] [Related]

  • 12. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.
    Vila M, Vukosavic S, Jackson-Lewis V, Neystat M, Jakowec M, Przedborski S.
    J Neurochem; 2000 Feb 15; 74(2):721-9. PubMed ID: 10646524
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies.
    Mori S, Fujitake J, Kuno S, Sano Y.
    Neurosci Lett; 1988 Jul 19; 90(1-2):57-62. PubMed ID: 2901058
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Sugama S, Wirz SA, Barr AM, Conti B, Bartfai T, Shibasaki T.
    Neuroscience; 2004 Jul 19; 128(2):451-8. PubMed ID: 15350655
    [Abstract] [Full Text] [Related]

  • 15. Increased dopamine synthesis in aging substantia nigra neurons.
    Greenwood CE, Tatton WG, Seniuk NA, Biddle FG.
    Neurobiol Aging; 1991 Jul 19; 12(5):557-65. PubMed ID: 1685220
    [Abstract] [Full Text] [Related]

  • 16. Role of dopamine transporter against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
    Kurosaki R, Muramatsu Y, Watanabe H, Michimata M, Matsubara M, Imai Y, Araki T.
    Metab Brain Dis; 2003 Jun 19; 18(2):139-46. PubMed ID: 12822832
    [Abstract] [Full Text] [Related]

  • 17. A stereological study on the neuroprotective actions of acute modafinil treatment on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigral lesions of the male black mouse.
    Aguirre JA, Cintra A, Hillion J, Narváez JA, Jansson A, Antonelli T, Ferraro L, Rambert FA, Fuxe K.
    Neurosci Lett; 1999 Nov 19; 275(3):215-8. PubMed ID: 10580713
    [Abstract] [Full Text] [Related]

  • 18. Systemic administration of proteasome inhibitor protects against MPTP neurotoxicity in mice.
    Oshikawa T, Kuroiwa H, Yano R, Yokoyama H, Kadoguchi N, Kato H, Araki T.
    Cell Mol Neurobiol; 2009 Jul 19; 29(5):769-77. PubMed ID: 19370411
    [Abstract] [Full Text] [Related]

  • 19. Dietary administration of paraquat for 13 weeks does not result in a loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice.
    Minnema DJ, Travis KZ, Breckenridge CB, Sturgess NC, Butt M, Wolf JC, Zadory D, Beck MJ, Mathews JM, Tisdel MO, Cook AR, Botham PA, Smith LL.
    Regul Toxicol Pharmacol; 2014 Mar 19; 68(2):250-8. PubMed ID: 24389362
    [Abstract] [Full Text] [Related]

  • 20. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
    Ricaurte GA, Irwin I, Forno LS, DeLanney LE, Langston E, Langston JW.
    Brain Res; 1987 Feb 10; 403(1):43-51. PubMed ID: 3493827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.